";s:4:"text";s:3849:"0000007224 00000 n
If the patient does not have a withdrawal bleed during the tablet free interval following the end of the second pack, the possibility of pregnancy must be ruled out before resuming with the next pack.For women receiving long-term therapy with enzyme inducers, another method of contraception should be used.The following have been shown to have clinically important interactions with COCs:Note: There are other antiretroviral agents that may increase plasma concentration of sex hormones.Strong and moderate CYP3A4 inhibitors such as azole antifungals (e.g. But all contraceptive pills have these advantages, and the evidence for supporting one over the other is limited or conflicting. • Presence or risk of venous thromboembolism (VTE)o Venous thromboembolism – current VTE (on anticoagulants) or history of (e.g. The decision to use Microgynon 30 ED should be taken after a discussion with the woman to ensure she understands the risk of VTE with Microgynon 30 ED, how her current risk factors influence this risk, and that her VTE risk is highest in the first ever year of use. First signs of thrombosis or blood clots (e.g. Colombia. The substance concentration then falls in 2 phases for which half-lives of around 1 - 2 hours and about 20 hours have been determined. Very rarely, the Pill has also been linked with some forms of liver cancer in women who have taken it for a long time.Some women using hormonal contraceptives including Microgynon 30 ED have reported depression or depressed mood.
Recurrence of cholestatic jaundice and/or cholestasis-related pruritus which occurred during pregnancy or previous use of sex steroids necessitates the discontinuation of COCs.Insulin-dependent diabetics without vascular disease can use COCs. You take an ‘active pill’ each day for 21 days, followed by an ‘inactive pill’ each day for 7 days.Microgynon 30 ED will not protect you against sexually transmitted infections, such as Chlamydia or HIV. 4.5 Interaction with other medicinal products and other forms of interaction6.6 Special precautions for disposal and other handling9. 0000001798 00000 n
For technical reasons, these data can only be calculated at higher dosages.An imaginary distribution volume of around 5 l/kg and a metabolic clearance rate from plasma of approx. Other side effects include: dizziness, increased serum triglycerides, tremor, dyspepsia, hot flash, palpitations, vertigo, abnormal dreams, bitter taste, decreased libido, and diaphoresis.